Insmed Incorporated
-
Ticker
INSM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Bridgewater, New Jersey
Insmed Incorporated, a biopharmaceutical company, focuses on developing and commercializing inhaled therapies for patients with serious lung diseases. Its lead product candidate is ARIKAYCE, an inhaled antibiotic treatment that delivers an anti-infective directly to the site of serious lung infections.
REPORT RATINGS
4.8 / 5.0 (156)
Insmed Incorporated reports have an aggregate usefulness score of 4.8 based on 156 reviews.
Insmed Incorporated
Most Recent Annual Report
MOST RECENT
2022 Annual Report and Form 10K
Older/Archived Annual Reports